Lindbrook Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $6.64K | Sell |
198
-27
| -12% | -$906 | ﹤0.01% | 1836 |
|
|
2024
Q4 | $8.82K | Sell |
225
-4
| -2% | -$157 | ﹤0.01% | 1714 |
|
|
2024
Q3 | $9.02K | Sell |
229
-94
| -29% | -$3.7K | ﹤0.01% | 1725 |
|
|
2024
Q2 | $12.6K | Buy |
323
+320
| +10,667% | +$12.5K | ﹤0.01% | 1503 |
|
|
2024
Q1 | $129 | Buy |
+3
| New | +$129 | ﹤0.01% | 2606 |
|
|
2023
Q4 | – | Sell |
-14
| Closed | -$478 | – | 2846 |
|
|
2023
Q3 | $478 | Buy |
+14
| New | +$478 | ﹤0.01% | 2548 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2879 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2948 |
|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$15K | – | 2226 |
|
|
2021
Q3 | $15K | Buy |
+1,000
| New | +$15K | ﹤0.01% | 851 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2016 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1952 |
|
|
2019
Q3 | – | Sell |
-750
| Closed | -$7K | – | 1545 |
|
|
2019
Q2 | $7K | Buy |
+750
| New | +$7K | ﹤0.01% | 996 |
|